Head of German medicines body likens HRT to thalidomideBMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7418.767 (Published 02 October 2003) Cite this as: BMJ 2003;327:767
- Jane Burgermeister
Doctors in Germany should drastically reduce the amount of hormone replacement therapy (HRT) that they prescribe to older women, a key commission has recommended.
Issuing its first guidelines on HRT to doctors in Germany, the country's Commission on the Safety of Medicines said that new international studies had shown that the risks of HRT clearly outweighed the benefits.
It recommended that doctors offer the treatment only to women with particularly severe menopausal symptoms. It also recommended that treatment …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial